The quantification of blood glucose revealed that the deletion of osteoblastic RegIIIγ partially inhibited the decrease in blood glucose and impaired glucose tolerance in the Vhl cKO mice with T1DM (Fig. 4d, e). This evidence concerns the gene VHL and type 1 diabetes mellitus.